Access Pharmaceuticals
About Us
Board of Directors
Senior Management
Product Programs
MuGard
ProLindac
Chemistry
Preclinical data
Future Development
Cobalamin mediated oral drug delivery
Thiarabine
Cobalamin targeted delivery
Publications
Business Development
Investor Relations
Newsroom
2010
2009
Contact Us
Product Programs
MuGard
ProLindac
Cobalamin mediated oral drug delivery
Thiarabine
Cobalamin targeted delivery
Publications
Product Pipeline
Sign up for news alerts!
Latest Product Programs News & Events
06.15.10
Access Pharma Initiates U.S. MuGard Sampling Program With Leading Oncology Groups
06.10.10
Access Pharma Presents at the California Nanosystems Institute Conference Focused on Targeted Delivery of RNAi Therapeutics
04.15.10
Access Pharma Collaborates With Leading Oral Mucositis Expert to Further Support MuGard Commercialization Efforts
04.13.10
Access Pharma Announces Successful Completion of First North American MuGard Commercial Production Run
03.25.10
Access Pharma's Korean Partner Gains Marketing Approval for MuGard
More News